CLINICAL_TRIALS
trial_result
· 2019-04-01
Clinical Trial Update: A Clinical Trial of Lurasidone in Treatment of Schizophrenia [Phase 3]
Summary
Phase 3 clinical trial update for lurasidone in schizophrenia has completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma (Suzhou) Co., Ltd. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2019-04-01